One of the greatest challenges in dermatology is the vast number of different types of skin disorders.
These disorders can then manifest themselves in a variety of different ways based off patient-specific factors that make it difficult to accurately diagnose the problem.
A lesion, rash or pigment change could be the result of inflammation, infection, or a more significant acute or chronic pathological process. Many infectious diseases such as human papillomavirus, tinea, herpes, measles, varicella and impetigo have primary skin manifestations and may be quickly identified. However, there are other skin disorders that present with atypical presentations that may require rapid and accurate diagnostics combined with an expert team of pathologists to gain a full understanding of the clinical presentation.
Clinical Solution
Vikor Scientific™ offers the clinician access to the most advanced molecular methodology for pathogen detection, quantification, and resistance gene identification. Vikor delivers rapid and precise results simultaneously through a value-based technology platform, ABXAssist™, which incorporates regional sensitivity and susceptibility patterns, medication costs, antibiotic spectrum of activity, and FDA guidance.
The end product is a patient-centered, value-based care solution that enables providers to make informed treatment decisions that could avoid inappropriate therapy, excess costs, adverse drug events and the progression of disease.
Clinical Advantages
- Prevents delays in diagnosis and treatment (*results within 24 to 48 hours post specimen arrival to lab)
- Detects polymicrobial infections simultaneously
- Identifies up to 49 antibiotic resistance genes in 12 antibiotic categories including Methicillin, Carbapenem and Vancomycin resistance
- Markedly less susceptible to being affected by concurrent antibiotic therapy
- Reduces unnecessary drug exposure and adverse events
- Decreases the progression and spread of infection
- Provides up-to-date regional sensitivity and susceptibility patterns
- Improves selection of narrow-spectrum antibiotics
- Prepares clinicians to make cost-effective treatment decisions
- Easily accessible results (mobile, web-portal or EMR integration)
* Test results could be delayed in some circumstances when there is error in clerical documentation, collections, lab handling, or a delay in shipping.
